Skip to content

REGEN BIOPHARMA, INC.

RGBP RGBPP

CIK 0001589150

← back to feed
Revenue (TTM)
$236.26K
0.0% YoY Q2 May 2026
Net Income (TTM)
−$162.57K
−90.7% YoY Q2 May 2026
EPS Diluted (TTM)
−$0.02
+68.8% YoY Q2 May 2026
Gross Margin
—
Q2 May 2026
Operating Margin
-363.8%
Q2 May 2026
Net Margin
-68.8%
Q2 May 2026
Free Cash Flow (TTM)
—
Q2 May 2026
Cash
$271
Q2 May 2026
Total Debt
$107.06K
Q2 May 2026
Shares Outstanding
511.96M sh
Q2 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings